175 related articles for article (PubMed ID: 35395239)
1. Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A
Vlachodimou A; de Vries H; Pasoli M; Goudswaard M; Kim SA; Kim YC; Scortichini M; Marshall M; Linden J; Heitman LH; Jacobson KA; IJzerman AP
Biochem Pharmacol; 2022 Jun; 200():115027. PubMed ID: 35395239
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
Kim SA; Marshall MA; Melman N; Kim HS; Müller CE; Linden J; Jacobson KA
J Med Chem; 2002 May; 45(11):2131-8. PubMed ID: 12014951
[TBL] [Abstract][Full Text] [Related]
3. Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.
Kim YC; Ji X; Melman N; Linden J; Jacobson KA
J Med Chem; 2000 Mar; 43(6):1165-72. PubMed ID: 10737749
[TBL] [Abstract][Full Text] [Related]
4. Exploring Biginelli-based scaffolds as A
Prieto-Díaz R; Fojo-Carballo H; Majellaro M; Tandarić T; Azuaje J; Brea J; Loza MI; Barbazán J; Salort G; Chotalia M; Rodríguez-Pampín I; Mallo-Abreu A; Rita Paleo M; García-Mera X; Ciruela F; Gutiérrez-de-Terán H; Sotelo E
Biomed Pharmacother; 2024 Apr; 173():116345. PubMed ID: 38442670
[TBL] [Abstract][Full Text] [Related]
5. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
[TBL] [Abstract][Full Text] [Related]
6. Irreversible Antagonists for the Adenosine A
Temirak A; Schlegel JG; Voss JH; Vaaßen VJ; Vielmuth C; Claff T; Müller CE
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744918
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Effect of Halogenation in a Series of Potent and Selective A
Prieto-Díaz R; González-Gómez M; Fojo-Carballo H; Azuaje J; El Maatougui A; Majellaro M; Loza MI; Brea J; Fernández-Dueñas V; Paleo MR; Díaz-Holguín A; Garcia-Pinel B; Mallo-Abreu A; Estévez JC; Andújar-Arias A; García-Mera X; Gomez-Tourino I; Ciruela F; Salas CO; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2023 Jan; 66(1):890-912. PubMed ID: 36517209
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
9. A
Tay AHM; Prieto-Díaz R; Neo S; Tong L; Chen X; Carannante V; Önfelt B; Hartman J; Haglund F; Majellaro M; Azuaje J; Garcia-Mera X; Brea JM; Loza MI; Jespers W; Gutierrez-de-Teran H; Sotelo E; Lundqvist A
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580926
[TBL] [Abstract][Full Text] [Related]
10. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice.
Eckle T; Grenz A; Laucher S; Eltzschig HK
J Clin Invest; 2008 Oct; 118(10):3301-15. PubMed ID: 18787641
[TBL] [Abstract][Full Text] [Related]
11. Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonists.
Baraldi PG; Baraldi S; Saponaro G; Preti D; Romagnoli R; Piccagli L; Cavalli A; Recanatini M; Moorman AR; Zaid AN; Varani K; Borea PA; Tabrizi MA
J Med Chem; 2012 Jan; 55(2):797-811. PubMed ID: 22148859
[TBL] [Abstract][Full Text] [Related]
12. Medicinal chemistry and pharmacology of A2B adenosine receptors.
Volpini R; Costanzi S; Vittori S; Cristalli G; Klotz KN
Curr Top Med Chem; 2003; 3(4):427-43. PubMed ID: 12570760
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists.
Strappaghetti G; Corsano S; Barbaro R; Giannaccini G; Betti L
Bioorg Med Chem; 2001 Mar; 9(3):575-83. PubMed ID: 11310591
[TBL] [Abstract][Full Text] [Related]
14. 1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.
Borrmann T; Hinz S; Bertarelli DC; Li W; Florin NC; Scheiff AB; Müller CE
J Med Chem; 2009 Jul; 52(13):3994-4006. PubMed ID: 19569717
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of triazole-pyrimidine-methylbenzonitrile derivatives as dual A
Li Z; Kou L; Fu X; Xie Z; Xu M; Guo L; Lin T; Gong S; Zhang S; Liu M
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1514-1526. PubMed ID: 35616298
[TBL] [Abstract][Full Text] [Related]
17. Tritium-labeled agonists as tools for studying adenosine A
Hinz S; Alnouri WM; Pleiss U; Müller CE
Purinergic Signal; 2018 Sep; 14(3):223-233. PubMed ID: 29752618
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological evaluation of novel 1,3,8- and 1,3,7,8-substituted xanthines as adenosine receptor antagonists.
Rodríguez-Borges JE; García-Mera X; Balo MC; Brea J; Caamaño O; Fernández F; López C; Loza MI; Nieto MI
Bioorg Med Chem; 2010 Mar; 18(5):2001-9. PubMed ID: 20137957
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of endogenous A
Goulding J; May LT; Hill SJ
Biochem Pharmacol; 2018 Jan; 147():55-66. PubMed ID: 29106905
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts.
Brackett LE; Daly JW
Biochem Pharmacol; 1994 Mar; 47(5):801-14. PubMed ID: 8135856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
